» Articles » PMID: 6689734

Alpha Interferon for Induction of Remission in Hairy-cell Leukemia

Overview
Journal N Engl J Med
Specialty General Medicine
Date 1984 Jan 5
PMID 6689734
Citations 112
Authors
Affiliations
Soon will be listed here.
Abstract

We treated seven patients who had progressive hairy-cell leukemia with daily doses of 3 million units of partially pure alpha (leukocyte) interferon by the intramuscular route. Three patients had a complete remission, and four had a partial remission, according to strict criteria for a response. After treatment, bone-marrow aspirates showed an absence of leukemia cells in three patients and 5 per cent or fewer in three others. Normalization of subnormal peripheral-blood values occurred in six of six patients with anemia, in seven of seven with granulocytopenia, and in four of four with thrombocytopenia. Remissions have been maintained for over 6 to over 10 months. Alpha interferon appears to be highly effective in patients with hairy-cell leukemia.

Citing Articles

Cytokines in cancer.

Kureshi C, Dougan S Cancer Cell. 2024; 43(1):15-35.

PMID: 39672170 PMC: 11841838. DOI: 10.1016/j.ccell.2024.11.011.


Recommendations for the Management of Patients with Hairy-Cell Leukemia and Hairy-Cell Leukemia-like Disorders: A Work by French-Speaking Experts and French Innovative Leukemia Organization (FILO) Group.

Paillassa J, Maitre E, Belarbi Boudjerra N, Madani A, Benlakhal R, Matthes T Cancers (Basel). 2024; 16(12).

PMID: 38927891 PMC: 11201647. DOI: 10.3390/cancers16122185.


Noncovalently particle-anchored cytokines with prolonged tumor retention safely elicit potent antitumor immunity.

Niu L, Jang E, Chin A, Huo Z, Wang W, Cai W Sci Adv. 2024; 10(16):eadk7695.

PMID: 38640236 PMC: 11029804. DOI: 10.1126/sciadv.adk7695.


From bench to bedside: the history and progress of CAR T cell therapy.

Mitra A, Barua A, Huang L, Ganguly S, Feng Q, He B Front Immunol. 2023; 14:1188049.

PMID: 37256141 PMC: 10225594. DOI: 10.3389/fimmu.2023.1188049.


The protective role of the microenvironment in hairy cell leukemia treatment: Facts and perspectives.

Gargiulo E, Giordano M, Niemann C, Moussay E, Paggetti J, Morande P Front Oncol. 2023; 13:1122699.

PMID: 36968995 PMC: 10031020. DOI: 10.3389/fonc.2023.1122699.